The first multiethnic longitudinal study of the menopause ever done in the US, the Study of Women's Health Across the Nation (SWAN) is changing our ideas about the change of life.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More